A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes

Diabetes Care

Volumn 37, Issue 7, 2014, Pages 1885-1891

  Maahs, David M ^a   Calhoun, Peter ^b   Buckingham, Bruce A ^c   Chase, H Peter ^a   Hramiak, Irene ^d   Lum, John ^b   Cameron, Fraser ^e   Bequette, B Wayne ^e   Aye, Tandy ^c   Paul, Terri ^d   Slover, Robert ^a   Wadwa, R Paul ^a   Wilson, Darrell M ^c   Kollman, Craig ^b   Beck, Roy W ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

^e RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HOME MONITORING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; NOCTURNAL HYPOGLYCEMIA; PATIENT SAFETY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; HYPOGLYCEMIA; INSULIN INFUSION; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84903516856     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2159     Document Type: Article

References (32)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010;33:1004-1008
2. Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F. Duration of nocturnal hypoglycemia before seizures. Diabetes Care 2008;31:2110-2112
3. Bergenstal RM, Klonoff DC, Garg SK, et al.; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232
4. Buckingham B, Chase HP, Dassau E, et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010;33:1013-1017
5. Cameron F, Wilson DM, Buckingham BA, et al. Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. J Diabetes Sci Tech 2012;6:1142-1147
6. Buckingham BA, Cameron F, Calhoun P, et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 2013;15:622-627
7. Beck RW, Calhoun PM, Kollman C. Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther 2012;14:877-882
8. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751
9. Kovatchev BPRE, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858
10. O'Grady MJ, Retterath AJ, Keenan DB, et al. The use of an automated, portable glucose control systemfor overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:2182-2187
11. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833
12. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012;35:2148-2155
13. Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998;21:817-821 (Pubitemid 28487078)
14. Beck RW, Kollman C, Xing D, Buckingham BA, Chase HP. Outcome measures for outpatient hypoglycemia prevention studies. J Diabetes Sci Tech 2011;5:999-1004
15. Castillo MJ, Scheen AJ, Lefèbvre PJ. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level. J Clin Endocrinol Metab 1996;81:1975-1978 (Pubitemid 26152494)
16. Krzentowski G, Scheen A, Castillo M, Luyckx AS, Lefèbvre PJ. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia 1983;24:314-318 (Pubitemid 13092213)
17. Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care 2012;35:1462-1465
18. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240-1247
19. Orsini-Federici M, Akwi JA, Canonico V, et al. Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes. Diabetes Technol Ther 2006;8:67-75
20. Pickup JC, Viberti GC, Bilous RW, et al. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 1982;22:175-179 (Pubitemid 12183675)
21. Sherr JL, Collazo MP, Cengiz E, et al. Safety of nighttime 2-hour suspension of basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care 2014;37:773-779
22. Elleri D, Allen JM, Nodale M, et al. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescentswith Type 1 diabetes. Diabet Med 2010;27:480-484
23. Buckingham B, Block J, Burdick J, et al.; Diabetes Research in Children Network. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther 2005;7:440-447 (Pubitemid 40847806)
24. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997;20:22-25 (Pubitemid 27020036)
25. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabetes Care 1999;22(Suppl. 2):B40-B42 (Pubitemid 29107147)
26. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 1997;46:271-286
27. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
28. Beck RW, Hirsch IB, Laffel L, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383
29. Fiallo-Scharer R, Cheng J, Beck RW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care 2011;34:586-590
30. Kowalski AJ. Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. Diabetes Technol Ther 2009;11(Suppl. 1):S113-S119
31. Nimri R, Danne T, Kordonouri O, et al. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes 2013;14:159-167
32. Nimri R, Muller I, Atlas E, et al. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2014;15:91-99 Kidney Diseases